KOTLER KEVIN 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-20 3:50 pm Purchase | 2022-12-12 | 13G | Relmada Therapeutics, Inc. RLMD | KOTLER KEVIN | 1,899,930 6.300% | 1,899,930 (New Position) | Filing |